Atrial Fibrillation
2002; Lippincott Williams & Wilkins; Volume: 106; Issue: 1 Linguagem: Inglês
10.1161/01.cir.0000022730.66617.d9
ISSN1524-4539
Autores Tópico(s)Cardiac Arrhythmias and Treatments
ResumoHomeCirculationVol. 106, No. 1Atrial Fibrillation Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBAtrial Fibrillation Johan E.P. Waktare, MB, ChB, MRCP Johan E.P. WaktareJohan E.P. Waktare From the Cardiology Department, University Hospital Birmingham, Edgebaston, Birmingham, UK. Originally published2 Jul 2002https://doi.org/10.1161/01.CIR.0000022730.66617.D9Circulation. 2002;106:14–16A trial fibrillation (AF) is the most common cardiac arrhythmia and effects nearly 1% of the population. Its prevalence increases with increasing age; it is relatively infrequent in those under 40 years old, but occurs in up to 5% of those over 80 years of age.Normal Heart Electrical Activity and What Goes Wrong in AFThe heart is essentially a large muscular pump that drives blood around the body. To do this effectively, the heart's chambers must be precisely controlled electrically (Figure 1). The normal heartbeat begins with the natural pacemaker (the sinoatrial [SA] node) in the top right heart chamber (the right atrium). Activity spreads across the atria, causing them to contract. The contraction of the atria propels extra blood into the ventricles, which are the main pumping chambers. The electrical signal is delayed by about one tenth of a second by a special structure called the atrioventricular (AV) node, and then spreads rapidly across the ventricles to make them contract. Extra filling of the ventricles by the atria is not vital, but does serve to "prime the ventricular pump" and improve overall heart function. Download figureDownload PowerPointFigure 1. The atria contain the heart's natural pacemaker, the SA node, and are the part of the heart affected by atrial fibrillation. The ventricles are the muscular part of the heart that actually pump the blood. They are electrically isolated from the atria, and the only way the electrical signal can reach them is via the AV node.Normal heart rhythm is termed sinus rhythm. Most people have a resting heart rate of between 60 and 80 beats per minute (Figure 2). In AF, the atria contract rapidly and irregularly at rates of 400 to 600 beats per minute. Fortunately, the AV node will not allow many signals through to the ventricles; only about 1 or 2 out of every 3 atrial beats passes to the ventricles. The ventricles beat too fast, however, at rates of 110 to 180 beats per minute. Download figureDownload PowerPointFigure 2. A, Sinus rhythm. During normal sinus rhythm, the heartbeat is a single carefully coordinated process beginning in the SA node (1). The electrical signal spreads across the atria (2) and via the AV node (3) to the ventricles (4). B, Atrial fibrillation. When patients are in AF, the atria are constantly activating in a chaotic way because of multiple electrical signals firing at 400 to 600 beats per minute (1). The AV node (2) filters out most of these extra signals but still usually allows more beats to reach the ventricles than normal (3).Who Gets AF and Patterns of AFCardiac disorders such as coronary heart disease, heart valve problems, and heart failure predispose patients to AF, but it can occur in people with otherwise normal hearts. Indeed, about half of younger patients with AF have no associated cardiac disorders. AF can occur with different patterns. Examples of case histories are given below to illustrate the wide clinical spectrum of AF.Paroxysmal AFIn paroxysmal AF, the heart changes from sinus rhythm to AF for episodes lasting anywhere from seconds to days. The patient may only have 1 episode a year or be in AF most of the time, but the essential feature is that most episodes terminate spontaneously.Case Report: Paroxysmal AF in a Young Patient With No Other Heart ConditionPatient A had no cardiac problems until she began to suffer episodes of palpitations at the age of 35. She stated that these were so bad that she thought she was going to die. Paroxysmal AF was diagnosed and drug treatment instituted. Her attacks are now much less frequent and less severe. Currently she is content to continue with drug therapy, but her cardiologist has explained that if the attacks worsen, she could be offered an ablation to try to cure the condition.Persistent AFPersistent AF does not stop spontaneously, but sinus rhythm can be restored by medical intervention in the form of medication or, more commonly, by an electrical shock to the heart (DC cardioversion).Case Report: The Vague Symptoms of Persistent AFPatient B had a severe, persistent chest infection. He became breathless walking on the smallest incline. At a routine check for his high blood pressure, his physician discovered the patient was in persistent AF. He was given anticoagulants and scheduled for a cardioversion. The cardioversion was successful, but after several days the patient showed no improvement. His physician explained that he had relapsed into AF and needed extra treatment with an antiarrhythmic medication and another cardioversion. After the second cardioversion, his effort capacity was back to normal, and 6 months later he had stopped taking the coumadin, although his physician recommended that he stay on the antiarrhythmic medication for at least 2 years.Permanent AFPermanent AF is present all the time, and restoring sinus rhythm is either not possible or is not deemed appropriate.Case Report: Ablate and Pace for Permanent AFPatient C was elderly and had suffered from AF for many years. She had been cardioverted, but after consulting her physician, she decided to accept permanent AF. The problem was that her heart rate was still too fast despite rate limiting drugs. Her physician recommended AV nodal ablation and pacemaker implantation. After these procedures she felt much better. She is still taking coumadin but she has stopped all the other medication, and she reports that she feels better than she has for years.Is AF Bad for You?For most people, AF causes unpleasant symptoms but causes no harm. Complications can arise in some patients, but the risk of this occurring is greatly reduced by appropriate treatment.Adverse SymptomsMost, but not all, patients feel unwell with AF. It is not fully understood why the symptomatic impact is so variable. Palpitations (a sensation of a rapid and irregular heart beat) are the most frequent symptoms in those with paroxysmal AF. This can cause the patient to worry that they will have a heart attack or that their heart will stop. This rarely occurs, but urgent medical advice should be sought for any new cardiac symptom so that a precise diagnosis can be made. Those with persistent or permanent AF tend to notice palpitations less, perhaps because the heartbeat is constantly irregular. The switching back and forth between regular and irregular rhythms is what causes palpitations in many patients. When AF is persistent or permanent, patients more often suffer non-specific symptoms like poor effort tolerance, breathlessness on exertion, and lack of energy.StrokeThe quivering atria beat too rapidly to contract effectively, and with time they tend to enlarge. Both of these factors can lead to blood clots forming within the atria, and if these break loose they may lodge in other parts of the circulation. The most common site for this is the brain, and this results in a stroke.Heart failureIf the ventricles are allowed to beat rapidly for prolonged periods, they can weaken, and heart failure ensues. This is a rare complication, as most patients seek treatment before heart failure occurs. However, AF is a less efficient rhythm than sinus rhythm and can worsen preexisting heart failure.Treatments Available for AFAF is a very diverse condition effecting a wide range of patients, so there are few generalizations about what treatment is needed. With recent advances in drug and interventional treatments, a satisfactory outcome is now usually eventually obtained in most patients.DC CardioversionDC cardioversion is used to restore sinus rhythm in those with persistent AF. A brief general anesthetic is given intravenously and a defibrillator (the electrical shocking device used to treat cardiac arrest) is used to put the heart back into normal rhythm. The treatment is highly effective, with over 90% of patients reverting to sinus rhythm. Over the ensuing hours, days, and months, however, patients may relapse into AF.Rate Limiting DrugsRate limiting drugs limit the number of impulses transmitted through the AV node (Figure 2) and slow the heart rate to make the patient more comfortable.Antiarrhythmic DrugsIn patients with paroxysmal AF, antiarrhythmic drugs reduce the frequency and duration of AF episodes. In those with persistent AF, they are administered primarily to prevent AF recurring after a DC cardioversion.Anticoagulant and Antiplatelet DrugsAnticoagulant and antiplatelet medications thin the blood and make it less prone to clotting, thereby reducing the risk of stroke. Coumadin (warfarin) is the usual medication used but is not suitable or necessary for all patients. In these cases, aspirin or clopidogrel may be used, but if the risk of stroke is very small, no treatment may be recommended.PacemakersThose patients whose natural pacemaker (SA node) is failing become prone to AF, and implanting a pacemaker can have the beneficial side effect of reducing the chance that AF will occur. Pacemakers can be used in combination with ablation of the AV node to treat AF. Ablation refers to a medical procedure where a very small (1 to 2 mm) portion of the heart's electrical conduction system (for example, the AV node) is eliminated in a carefully controlled fashion. This so-called "ablate and pace" strategy is usually highly effective at improving symptoms, but has drawbacks such as life-long requirement for anticoagulation and for pacemaker treatment.Radiofrequency Ablation and SurgeryOver the last 10 years, ablation has emerged as the optimal treatment for most forms of rapid heart rhythm, but its use in curing AF is very recent. As opposed to ablation of the AV node, the technique of radiofrequency ablation here refers to selective elimination of one or more sites in the atria to reduce the chance that AF will occur. Procedures for AF are currently prolonged and complex, and success rates only modest. It is therefore not always the best option; however, when it works, the AF is cured completely. Surgical approaches for curing AF are also considered in some cases.Reassurance and ExplanationThe importance of reassurance and explanation cannot be over-emphasized. Relatively simple treatment reduces enormously the risk of harm for those with persistent or permanent AF. Patients with infrequent episodes of short-lived paroxysmal AF may need no other treatment than proper evaluation followed by reassurance that the condition is benign. Finally, those with AF that is difficult to control need to be involved in decisions regarding which of the emerging treatments should be used and be reassured that, with time, satisfactory control of the AF can be achieved.FootnotesCorrespondence to Dr Johan E.P. Waktare, Cardiology Department, University Hospital Birmingham, Edgebaston, Birmingham, B15 2TH, UK. E-mail [email protected] Previous Back to top Next FiguresReferencesRelatedDetailsCited By Subasi A, Kontio E and Jafaritadi M (2022) Deep learning approaches for the cardiovascular disease diagnosis using smartphone 5G IoT and Edge Computing for Smart Healthcare, 10.1016/B978-0-323-90548-0.00010-3, (163-193), . Malone F, McCarthy E, Delassus P, Buhk J, Fiehler J and Morris L (2020) An in vitro assessment of atrial fibrillation flow types on cardiogenic emboli trajectory paths, Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, 10.1177/0954411920946873, 234:12, (1421-1431), Online publication date: 1-Dec-2020. Rezaei Yousefi Z, Parak J, Tarniceriu A, Harju J, Yli-Hankala A, Korhonen I and Vehkaoja A (2019) Atrial Fibrillation Detection from Wrist Photoplethysmography Data Using Artificial Neural Networks World Congress on Medical Physics and Biomedical Engineering 2018, 10.1007/978-981-10-9038-7_75, (399-404), . Almusallam M and Soudani A Embedded Solution for Atrial Fibrillation Detection Using Smart Wireless Body Sensors, IEEE Sensors Journal, 10.1109/JSEN.2019.2906238, 19:14, (5740-5750) Takano M and Ueno A Noncontact In-Bed Measurements of Physiological and Behavioral Signals Using an Integrated Fabric-Sheet Sensing Scheme, IEEE Journal of Biomedical and Health Informatics, 10.1109/JBHI.2018.2825020, 23:2, (618-630) Gopu G, Anitha T, Nagarajapandian M and Prabhakaran M (2019) Investigation of Telecardiology System to Detect Cardiac Abnormalities Telemedicine Technologies, 10.1016/B978-0-12-816948-3.00004-0, (43-55), . Narin A, Isler Y, Ozer M and Perc M (2018) Early prediction of paroxysmal atrial fibrillation based on short-term heart rate variability, Physica A: Statistical Mechanics and its Applications, 10.1016/j.physa.2018.06.022, 509, (56-65), Online publication date: 1-Nov-2018. Meßner N, Budjan J, Loßnitzer D, Papavassiliu T, Schad L, Weingärtner S and Zöllner F (2018) Saturation-Recovery Myocardial T1-Mapping during Systole: Accurate and Robust Quantification in the Presence of Arrhythmia, Scientific Reports, 10.1038/s41598-018-23506-z, 8:1, Online publication date: 1-Dec-2018. Razzaq N, Sheikh S, Zaidi T, Akhtar I and Ahmed S (2017) Automated Differentiation between Normal Sinus Rhythm, Atrial Tachycardia, Atrial Flutter and Atrial Fibrillation during Electrophysiology 2017 IEEE 17th International Conference on Bioinformatics and Bioengineering (BIBE), 10.1109/BIBE.2017.00-43, 978-1-5386-1324-5, (266-272) Cole C and Zimmerman R (2017) Anticoagulant options in atrial fibrillation, The Nurse Practitioner, 10.1097/01.NPR.0000526766.99089.4e, 42:12, (29-35), Online publication date: 15-Dec-2017. Nuryani N, Solikhah M, Nugoho A, Afdala A and Anzihory E (2016) RR-Interval variance of electrocardiogram for atrial fibrillation detection, Journal of Physics: Conference Series, 10.1088/1742-6596/776/1/012105, 776, (012105), Online publication date: 1-Nov-2016. He D, Winokur E and Sodini C An Ear-Worn Vital Signs Monitor, IEEE Transactions on Biomedical Engineering, 10.1109/TBME.2015.2459061, 62:11, (2547-2552) Aggarwal N, Selvendran S, Raphael C and Vassiliou V (2015) Atrial Fibrillation in the Young: A Neurologist's Nightmare, Neurology Research International, 10.1155/2015/374352, 2015, (1-9), . Chapa D, Akintade B, Thomas S and Friedmann E (2015) Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: A systematic review, Heart & Lung, 10.1016/j.hrtlng.2015.01.008, 44:3, (189-198), Online publication date: 1-May-2015. He D and Sodini C A 58 nW ECG ASIC With Motion-Tolerant Heartbeat Timing Extraction for Wearable Cardiovascular Monitoring, IEEE Transactions on Biomedical Circuits and Systems, 10.1109/TBCAS.2014.2346761, 9:3, (370-376) Sengeløv M, Jørgensen P, Jensen J, Bruun N, Olsen F, Fritz-Hansen T, Nochioka K and Biering-Sørensen T (2015) Global Longitudinal Strain Is a Superior Predictor of All-Cause Mortality in Heart Failure With Reduced Ejection Fraction, JACC: Cardiovascular Imaging, 10.1016/j.jcmg.2015.07.013, 8:12, (1351-1359), Online publication date: 1-Dec-2015. Alagoz C, Guez A, Cohen A and Bullinga J (2015) Spiral wave classification using normalized compression distance: Towards atrial tissue spatiotemporal electrophysiological behavior characterization 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 10.1109/EMBC.2015.7319395, 978-1-4244-9271-8, (4503-4506) Kim M, Kim Y and Cho Y (2015) Electrocardiographic characteristics of significant factors of detected atrial fibrillation using WEMS, Journal of the Korea Industrial Information Systems Research, 10.9723/jksiis.2015.20.6.037, 20:6, (37-46), Online publication date: 31-Dec-2016. Weingärtner S, Akçakaya M, Basha T, Kissinger K, Goddu B, Berg S, Manning W and Nezafat R (2013) Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability, Magnetic Resonance in Medicine, 10.1002/mrm.24761, 71:3, (1024-1034), Online publication date: 1-Mar-2014. Tseng K, Bor-Shyh Lin , Lun-De Liao , Yu-Te Wang and Yu-Lin Wang Development of a Wearable Mobile Electrocardiogram Monitoring System by Using Novel Dry Foam Electrodes, IEEE Systems Journal, 10.1109/JSYST.2013.2260620, 8:3, (900-906) Greener M (2010) The nurse's role in the management of atrial fibrillation, Nurse Prescribing, 10.12968/npre.2010.8.11.79787, 8:11, (532-537), Online publication date: 1-Nov-2010. Chin-Teng Lin , Kuan-Cheng Chang , Chun-Ling Lin , Chia-Cheng Chiang , Shao-Wei Lu , Shih-Sheng Chang , Bor-Shyh Lin , Hsin-Yueh Liang , Ray-Jade Chen , Yuan-Teh Lee and Li-Wei Ko An Intelligent Telecardiology System Using a Wearable and Wireless ECG to Detect Atrial Fibrillation, IEEE Transactions on Information Technology in Biomedicine, 10.1109/TITB.2010.2047401, 14:3, (726-733) I-Jan Wang , Lun-De Liao , Yu-Te Wang , Chi-Yu Chen , Bor-Shyh Lin , Shao-Wei Lu and Chin-Teng Lin (2010) A Wearable Mobile Electrocardiogram measurement device with novel dry polymer-based electrodes 2010 IEEE Region 10 Conference (TENCON 2010), 10.1109/TENCON.2010.5686658, 978-1-4244-6889-8, (379-384) Hickman M, Chelliah R, Burden L and Senior R (2010) Resting myocardial blood flow, coronary flow reserve, and contractile reserve in hibernating myocardium: implications for using resting myocardial contrast echocardiography vs. dobutamine echocardiography for the detection of hibernating myocardium, European Journal of Echocardiography, 10.1093/ejechocard/jeq062, 11:9, (756-762), Online publication date: 1-Oct-2010. Diaz J, Díaz M, Castro N, Glover B, Manoharan G and Escalona O (2007) Use of Support Vector Machines in Predicting Success of Intracardiac Cardioversion by Electric Shocks in Patients with Atrial Fibrillation IV Latin American Congress on Biomedical Engineering 2007, Bioengineering Solutions for Latin America Health, 10.1007/978-3-540-74471-9_271, (1168-1172), . Yaacobi M, Liel-Cohen N and Guterman H (2008) Simultaneous left atrium volume tracking from echocardiographic movies 2008 IEEE 25th Convention of Electrical and Electronics Engineers in Israel (IEEEI), 10.1109/EEEI.2008.4736558, 978-1-4244-2481-8, (403-407) Diaz J, Escalona O, Anderson J, Glover B and Adgey A Frequency Analysis of Atrial Fibrillation Predicts Success for Low Energy Intracardiac Cardioversion World Congress on Medical Physics and Biomedical Engineering 2006, 10.1007/978-3-540-36841-0_242, (1017-1020) Diaz J, Castro N, Escalona O, Anderson J, Glover B and Adgey J (2007) The effect of internal DC shocks on the atrial fibrillation frequency 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 10.1109/IEMBS.2007.4352859, 978-1-4244-0787-3, (2591-2594) Elhendy A (2006) Role of Stress Imaging Techniques in Evaluation of Patients Before and after Myocardial Revascularization Noninvasive Imaging of Myocardial Ischemia, 10.1007/1-84628-156-3_15, (247-257), . Biagini E, Elhendy A, Bax J, Schinkel A and Poldermans D (2005) The use of stress echocardiography for prognostication in coronary artery disease: an overview, Current Opinion in Cardiology, 10.1097/01.hco.0000175516.50181.c0, 20:5, (386-394), Online publication date: 1-Sep-2005. Knuesel P, Nanz D, Wyss C, Buechi M, Kaufmann P, von Schulthess G, Lüscher T and Schwitter J (2003) Characterization of Dysfunctional Myocardium by Positron Emission Tomography and Magnetic Resonance, Circulation, 108:9, (1095-1100), Online publication date: 2-Sep-2003. Gomis-Tena J, Saiz J and Ferrero J (2003) Inhibition of atrial action potentials alternans by calcium-activated chloride current blockade - simulation study Computers in Cardiology, 2003, 10.1109/CIC.2003.1291182, 0-7803-8170-X, (421-424) Mell J, Jordan D, Yuping Xiao , Yibin Zheng , Akar J and Haines D Wavelet analysis of atrial fibrillation electrograms International Conference on Acoustics, Speech and Signal Processing (ICASSP'03), 10.1109/ICASSP.2003.1202369, 0-7803-7663-3, (II-357-60) Pasic J, Levy W and Sullivan M (2003) Cytokines in Depression and Heart Failure, Psychosomatic Medicine, 10.1097/01.PSY.0000058372.50240.38, 65:2, (181-193), Online publication date: 1-Mar-2003. Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, Kottkamp H, Gummert J and Dhein S (2003) Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2003.07.014, 42:10, (1785-1792), Online publication date: 1-Nov-2003. Gomis-Tena J, Saiz J and Ferrero J Effect of calcium-activated chloride current blockade on alternans of atrial action potentials: simulation study 25th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 10.1109/IEMBS.2003.1279493, 0-7803-7789-3, (36-39) Yuping Xiao , Yibin Zheng , Jordan D, Akar J and Haines D Parameter estimation of spiral waves from atrial electrograms International Conference on Acoustics, Speech and Signal Processing (ICASSP'03), 10.1109/ICASSP.2003.1199914, 0-7803-7663-3, (V-245-8) Kotecha D, Ahmed A, Calvert M, Lencioni M, Terwee C, Lane D and Quinn T (2016) Patient-Reported Outcomes for Quality of Life Assessment in Atrial Fibrillation: A Systematic Review of Measurement Properties, PLOS ONE, 10.1371/journal.pone.0165790, 11:11, (e0165790) July 2, 2002Vol 106, Issue 1 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000022730.66617.D9PMID: 12093762 Originally publishedJuly 2, 2002 PDF download Advertisement
Referência(s)